Alcohol and Acute-on-Chronic Liver Failure

Jalan, 2014, Toward an improved definition of acute-on-chronic liver failure, Gastroenterology, 147, 4, 10.1053/j.gastro.2014.05.005 Bajaj, 2018, Acute-on-chronic liver failure: getting ready for prime-time, Hepatology, 68, 1621, 10.1002/hep.30056 Arroyo, 2020, Acute-on-chronic liver failure, N Engl J Med, 382, 2137, 10.1056/NEJMra1914900 Zaccherini, 2020, Acute-on-chronic liver failure: definitions, pathophysiology and principles of treatment, JHEP Rep, 3, 100176, 10.1016/j.jhepr.2020.100176 Bernal, 2015, Acute-on-chronic liver failure, Lancet, 386, 1576, 10.1016/S0140-6736(15)00309-8 Sarin, 2016, Acute-on-chronic liver failure: terminology, mechanisms and management, Nat Rev Gastroenterol Hepatol, 13, 131, 10.1038/nrgastro.2015.219 Hernaez, 2017, Acute-on-chronic liver failure: an update, Gut, 66, 541, 10.1136/gutjnl-2016-312670 Jalan, 2020, Acute-on-chronic liver failure: a new disease or an old one hiding in plain sight?, Clin Liver Dis (Hoboken), 15, S45 Moreau, 2021, Acute-on-chronic liver failure: a distinct clinical syndrome, J Hepatol, 75, S27, 10.1016/j.jhep.2020.11.047 Mezzano, 2021, Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis, Gut Gustot, 2019, Acute-on-chronic liver failure in patients with alcohol-related liver disease, J Hepatol, 70, 319, 10.1016/j.jhep.2018.12.008 Sarin, 2009, Acute-On-Chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL), Hepatol Int, 3, 269, 10.1007/s12072-008-9106-x Sarin, 2014, Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014, Hepatol Int, 8, 453, 10.1007/s12072-014-9580-2 Sarin, 2019, Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL): an update, Hepatol Int, 13, 353, 10.1007/s12072-019-09946-3 Bajaj, 2014, Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures, Hepatology, 60, 250, 10.1002/hep.27077 O'Leary, 2018, NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis, Hepatology, 67, 2367, 10.1002/hep.29773 Moreau, 2013, Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis, Gastroenterology, 144, 1426, 10.1053/j.gastro.2013.02.042 Jalan, 2014, Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure, J Hepatol, 61, 1038, 10.1016/j.jhep.2014.06.012 Hernaez, 2019, Prevalence and short-term mortality of acute-on-chronic liver failure: a national cohort study from the USA, J Hepatol, 70, 639, 10.1016/j.jhep.2018.12.018 Kim, 2016, Characteristics and discrepancies in acute-on-chronic liver failure: need for a unified definition, PLoS One, 11, e0146745, 10.1371/journal.pone.0146745 Amarapurkar, 2015, Acute-on-chronic liver failure: a prospective study to determine the clinical profile, outcome, and factors predicting mortality, Indian J Gastroenterol, 34, 216, 10.1007/s12664-015-0574-3 2018, Electronic address: [email protected]; European Association for the Study of the Liver. EASL clinical practice guidelines: management of alcohol-related liver disease, J Hepatol, 69, 154, 10.1016/j.jhep.2018.03.018 MacSween, 1986, Histologic spectrum of alcoholic liver disease, Semin Liver Dis, 6, 221, 10.1055/s-2008-1040605 Altamirano, 2014, A histologic scoring system for prognosis of patients with alcoholic hepatitis, Gastroenterology, 146, 1231, 10.1053/j.gastro.2014.01.018 Crabb, 2016, Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia, Gastroenterology, 150, 785, 10.1053/j.gastro.2016.02.042 Michelena, 2015, Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis, Hepatol Baltim Md, 62, 762, 10.1002/hep.27779 Sersté, 2018, The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis, J Hepatol, 69, 318, 10.1016/j.jhep.2018.02.022 Allen, 2016, Time trends in the health care burden and mortality of acute on chronic liver failure in the United States, Hepatology, 64, 2165, 10.1002/hep.28812 Clària, 2016, Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure, Hepatology, 64, 1249, 10.1002/hep.28740 Bernsmeier, 2015, Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK, Gastroenterology, 148, 603, 10.1053/j.gastro.2014.11.045 Albillos, 2014, Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance, J Hepatol, 61, 1385, 10.1016/j.jhep.2014.08.010 Orntoft, 2014, Short-term and long-term causes of death in patients with alcoholic hepatitis in Denmark, Clin Gastroenterol Hepatol, 12, 1739, 10.1016/j.cgh.2014.04.020 Karakike, 2017, Infections in severe alcoholic hepatitis, Ann Gastroenterol, 30, 152 Macdonald, 2018, Cell death markers in patients with cirrhosis and acute decompensation, Hepatol Baltim Md, 67, 989, 10.1002/hep.29581 Pasparakis, 2015, Necroptosis and its role in inflammation, Nature, 517, 311, 10.1038/nature14191 Khanova, 2018, Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients, Hepatol Baltim Md, 67, 1737, 10.1002/hep.29645 Louvet, 2015, Alcoholic liver disease: mechanisms of injury and targeted treatment, Nat Rev Gastroenterol Hepatol, 12, 231, 10.1038/nrgastro.2015.35 Fernández, 2018, Bacterial and fungal infections in acute on-chronic liver failure: prevalence, characteristics and impact on prognosis, Gut, 67, 1870, 10.1136/gutjnl-2017-314240 Lucey, 2009, Alcoholic hepatitis, N Engl J Med, 360, 2758, 10.1056/NEJMra0805786 Engelmann, 2020, Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure, J Hepatol, 73, 102, 10.1016/j.jhep.2020.01.011 Idya, 2018, Toll-like receptors: significance, ligands, signaling pathways, and functions in mammals, Int Rev Immunol, 37, 20, 10.1080/08830185.2017.1380200 Bird, 2008, Activation of stem cells in hepatic diseases, Cell Tissue Res, 331, 283, 10.1007/s00441-007-0542-z Gustot, 2014, Beneficial role of G-CSF in acute-on-chronic liver failure: effects on liver regeneration, inflammation/immunoparalysis or both?, Liver Int, 34, 484, 10.1111/liv.12356 Arroyo, 2014, Human serum albumin, systemic inflammation, and cirrhosis, J Hepatol, 61, 396, 10.1016/j.jhep.2014.04.012 Bernardi, 2020, Albumin in decompensated cirrhosis: new concepts and perspectives, Gut, 69, 1127, 10.1136/gutjnl-2019-318843 Ginès, 2009, Renal failure in cirrhosis, N Engl J Med, 361, 1279, 10.1056/NEJMra0809139 Piano, 2018, Association between grade of acute on chronic liver failure and response to terlipressin and albumin in patients with hepatorenal syndrome, Clin Gastroenterol Hepatol, 16, 1792, 10.1016/j.cgh.2018.01.035 Angus, 2013, Severe sepsis and septic shock, N Engl J Med, 369, 840, 10.1056/NEJMra1208623 Moreau, 2020, Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF, J Hepatol, 72, 688, 10.1016/j.jhep.2019.11.009 Choudhury, 2017, Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF Research Consortium (AARC) and CLIF-SOFA models, Hepatol Int, 11, 461, 10.1007/s12072-017-9816-z Cao, 2020, The Use of NACSELD and EASL-CLIF classification systems of ACLF in the prediction of prognosis in hospitalized patients with cirrhosis, Am J Gastroenterol, 115, 2026, 10.14309/ajg.0000000000000771 Cai, 2017, A nomogram for predicting prognostic value of inflammatory response biomarkers in decompensated cirrhotic patients without acute-on-chronic liver failure, Aliment Pharmacol Ther, 45, 1413, 10.1111/apt.14046 Forrest, 2017, Letter: there's something about the Neutrophil-to-Lymphocyte ratio (NLR)…, Aliment Pharmacol Ther, 46, 474, 10.1111/apt.14183 Trebicka, 2020, The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology, J Hepatol, 73, 842, 10.1016/j.jhep.2020.06.013 Maddrey, 1978, Corticosteroid therapy of alcoholic hepatitis, Gastroenterology, 75, 193, 10.1016/0016-5085(78)90401-8 Forrest, 2005, Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score, Gut, 54, 1174, 10.1136/gut.2004.050781 Dominguez, 2008, A new scoring system for prognostic stratification of patients with alcoholic hepatitis, Am J Gastroenterol, 103, 2747, 10.1111/j.1572-0241.2008.02104.x Gustot, 2015, Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis, Hepatology, 62, 243, 10.1002/hep.27849 Karvellas, 2018, Chronic liver failure consortium and European Foundation for the study of chronic liver failure. Dynamic prognostication in critically ill cirrhotic patients with multiorgan failure in ICUs in Europe and North America: a multicenter analysis, Crit Care Med, 46, 1783, 10.1097/CCM.0000000000003369 Louvet, 2007, The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids, Hepatology, 45, 1348, 10.1002/hep.21607 Mathurin, 2011, Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data, Gut, 60, 255, 10.1136/gut.2010.224097 Sundaram, 2019, Factors associated with survival of patients with severe acute-on-chronic liver failure before and after liver transplantation, Gastroenterology, 156, 1381, 10.1053/j.gastro.2018.12.007 Moreau, 2018, Effects of long-term norfloxacin therapy in patients with advanced cirrhosis, Gastroenterology, 155, 1816, 10.1053/j.gastro.2018.08.026 Bass, 2010, Rifaximin treatment in hepatic encephalopathy, N Engl J Med, 362, 1071, 10.1056/NEJMoa0907893 Kribben, 2012, Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure, Gastroenterology, 142, 782, 10.1053/j.gastro.2011.12.056 Bañares, 2013, Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial, Hepatology, 57, 1153, 10.1002/hep.26185 Thompson, 2018, Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: a multinational, prospective, controlled, randomized trial, Liver Transpl, 24, 380, 10.1002/lt.24986 Thursz, 2016, Treatment of severe alcoholic hepatitis, Gastroenterology, 150, 1823, 10.1053/j.gastro.2016.02.074 Carithers, 1989, Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial, Ann Intern Med, 110, 685, 10.7326/0003-4819-110-9-685 Mathurin, 1996, Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone, Gastroenterology, 110, 1847, 10.1053/gast.1996.v110.pm8964410 Verbeke, 2015, Prednisolone or pentoxifylline for alcoholic hepatitis, N Engl J Med, 373, 281, 10.1056/NEJMc1506342 Depew, 1980, Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy, Gastroenterology, 78, 524, 10.1016/0016-5085(80)90867-7 De, 2014, Pentoxifylline plus prednisolone versus pentoxifylline only for severe alcoholic hepatitis: a randomized controlled clinical trial, Ann Med Health Sci Res, 4, 810, 10.4103/2141-9248.141562 Theodossi, 1982, Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis, Gut, 23, 75, 10.1136/gut.23.1.75 Phillips, 2006, Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis–a randomised clinical trial, J Hepatol, 44, 784, 10.1016/j.jhep.2005.11.039 Moreno, 2010, Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial, J Hepatol, 53, 1117, 10.1016/j.jhep.2010.05.030 Nguyen-Khac, 2011, Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis, N Engl J Med, 365, 1781, 10.1056/NEJMoa1101214 Matsunaga, 2011, TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules, Mol Pharmacol, 79, 34, 10.1124/mol.110.068064 Rice, 2010, A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis, Crit Care Med, 38, 1685, 10.1097/CCM.0b013e3181e7c5c9 Naveau, 2004, A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis, Hepatology, 39, 1390, 10.1002/hep.20206 Xiang, 2020, Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice, J Hepatol, 72, 736, 10.1016/j.jhep.2019.11.013 Arab, 2020, An open label, dose escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcoholic hepatitis, Hepatology, 72, 441, 10.1002/hep.31046 Engelmann, 2021, Granulocyte-Colony Stimulating Factor (G-CSF) to treat acute-on-chronic liver failure, a multicenter randomized trial (GRAFT study), J Hepatol, 10.1016/j.jhep.2021.07.033 Newsome, 2018, Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial, Lancet Gastroenterol Hepatol, 3, 25, 10.1016/S2468-1253(17)30326-6 Philips, 2020, Granulocyte colony-stimulating factor use in decompensated cirrhosis: lack of survival benefit, J Clin Exp Hepatol, 10, 124, 10.1016/j.jceh.2019.05.003 Engelmann, 2021, The current status of granulocyte-colony stimulating factor to treat acute-on-chronic liver failure, Semin Liver Dis, 41, 298, 10.1055/s-0041-1723034 Philips, 2017, Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study, Clin Gastroenterol Hepatol, 15, 600, 10.1016/j.cgh.2016.10.029 Van Melkebeke, 2021, Treatment of severe alcoholic hepatitis: a systematic review, Curr Opin Pharmacol, 60, 91, 10.1016/j.coph.2021.06.011 Artru, 2017, Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3, J Hepatol, 67, 708, 10.1016/j.jhep.2017.06.009 Thuluvath, 2018, Liver transplantation in patients with multiple organ failures: feasibility and outcomes, J Hepatol, 69, 1047, 10.1016/j.jhep.2018.07.007 Mathurin, 2011, Early liver transplantation for severe alcoholic hepatitis, N Engl J Med, 365, 1790, 10.1056/NEJMoa1105703 Lee, 2018, Outcomes of early liver transplantation for patients with severe alcoholic hepatitis, Gastroenterology, 155, 422, 10.1053/j.gastro.2018.04.009 Herrick-Reynolds, 2021, Evaluation of early vs standard liver transplant for alcohol-associated liver disease, JAMA Surg, e213748 Zanetto, 2021, New indications for liver transplantation, J Clin Med, 10, 3867